MAI Capital Management Has $553,000 Position in McKesson Co. (NYSE:MCK)
MAI Capital Management Has $553,000 Position in McKesson Co. (NYSE:MCK)
MAI Capital Management cut its holdings in McKesson Co. (NYSE:MCK – Get Rating) by 34.4% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,695 shares of the company's stock after selling 890 shares during the quarter. MAI Capital Management's holdings in McKesson were worth $553,000 as of its most recent SEC filing.
麦资本管理公司最近提交给美国证券交易委员会的13F文件显示，该公司在第二季度减持了34.4%的麦凯森股份。该公司在本季度出售了890股后，持有1,695股该公司股票。截至最近提交给美国证券交易委员会的文件，迈资本管理公司持有的麦凯生股份价值55.3万美元。
Several other hedge funds have also recently bought and sold shares of MCK. BlackRock Inc. boosted its stake in McKesson by 2.1% in the 4th quarter. BlackRock Inc. now owns 13,171,252 shares of the company's stock worth $3,273,976,000 after purchasing an additional 269,506 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of McKesson by 4.1% in the first quarter. JPMorgan Chase & Co. now owns 5,965,095 shares of the company's stock valued at $1,826,096,000 after purchasing an additional 235,874 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of McKesson by 0.3% during the first quarter. Bank of New York Mellon Corp now owns 1,976,639 shares of the company's stock worth $605,109,000 after buying an additional 5,265 shares during the period. Norges Bank bought a new position in shares of McKesson during the fourth quarter worth about $386,729,000. Finally, Acadian Asset Management LLC raised its position in McKesson by 360.8% in the 1st quarter. Acadian Asset Management LLC now owns 1,077,083 shares of the company's stock valued at $329,689,000 after buying an additional 843,348 shares during the last quarter. 86.43% of the stock is currently owned by institutional investors and hedge funds.
其他几家对冲基金最近也买卖了MCK的股票。贝莱德股份有限公司在第四季度增持了麦凯森2.1%的股份。贝莱德股份有限公司在此期间增持了269,506股，目前持有该公司13,171,252股股票，价值3,273,976,000美元。摩根大通在第一季度增持了4.1%的McKesson股票。摩根大通目前持有5,965,095股该公司股票，价值1,826,096,000美元，上个季度又购买了235,874股。纽约梅隆银行(Bank Of New York Mellon Corp)在第一季度将其在McKesson股票的头寸增加了0.3%。纽约梅隆银行(Bank Of New York Mellon Corp)目前持有1,976,639股该公司股票，价值605,109,000美元，在此期间又购买了5,265股。挪威银行在第四季度购买了价值约386,729,000美元的McKesson股票新头寸。最后，Acadian Asset Management LLC在第一季度将其在McKesson的头寸提高了360.8。Acadian Asset Management LLC在上个季度额外购买了843,348股后，现在拥有1,077,083股该公司股票，价值329,689,000美元。86.43%的股票目前由机构投资者和对冲基金持有。
Wall Street Analyst Weigh In
华尔街分析师也加入进来
A number of research firms have weighed in on MCK. Mizuho upped their price target on McKesson from $331.00 to $345.00 and gave the stock a "neutral" rating in a research report on Thursday, August 4th. Credit Suisse Group increased their target price on shares of McKesson from $377.00 to $385.00 and gave the stock an "outperform" rating in a report on Monday, August 8th. Argus lifted their price target on shares of McKesson from $370.00 to $430.00 and gave the company a "buy" rating in a research note on Monday, September 12th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of McKesson from $378.00 to $409.00 in a research note on Monday, August 8th. Finally, Robert W. Baird lifted their target price on McKesson from $386.00 to $400.00 and gave the company an "outperform" rating in a research report on Thursday, August 4th. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus target price of $352.46.
一些研究公司已经对MCK发表了看法。瑞穗在8月4日周四的一份研究报告中将麦克森的目标价从331.00美元上调至345.00美元，并给予该股“中性”评级。瑞士信贷集团在8月8日周一的一份报告中将麦克森股票的目标价从377.00美元上调至385.00美元，并给予该股“跑赢大盘”的评级。2012年9月12日，阿格斯在一份研究报告中将麦凯森股票的目标价从370.00美元上调至430.00美元，并给予该公司“买入”评级。德意志银行在8月8日周一的一份研究报告中将麦凯森股票的目标价从378.00美元上调至409.00美元。最后，罗伯特·W·贝尔德在8月4日的一份研究报告中将麦凯森的目标价从386.00美元上调至400.00美元，并给予该公司“跑赢大盘”的评级。一位分析师对该股的评级为持有，11位分析师给出了买入评级，一位分析师给出了强烈的买入评级。根据MarketBeat.com的数据，该股目前的平均评级为买入，共识目标价为352.46美元。
McKesson Stock Performance
McKesson股票表现
McKesson (NYSE:MCK – Get Rating) last announced its earnings results on Wednesday, August 3rd. The company reported $5.83 earnings per share for the quarter, topping analysts' consensus estimates of $5.31 by $0.52. The company had revenue of $67.15 billion for the quarter, compared to analyst estimates of $63.87 billion. McKesson had a negative return on equity of 350.22% and a net margin of 0.52%. As a group, equities analysts forecast that McKesson Co. will post 24.42 earnings per share for the current year.
McKesson(纽约证券交易所代码：MCK-GET Rating)上一次公布收益结果是在8月3日星期三。该公司公布本季度每股收益为5.83美元，比分析师普遍预期的5.31美元高出0.52美元。该公司本季度营收为671.5亿美元，而分析师预期为638.7亿美元。麦克森的净资产回报率为负350.22%，净利润率为0.52%。作为一个整体，股票分析师预计McKesson Co.本年度每股收益为24.42美元。
McKesson Increases Dividend
麦凯森增加股息
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 3rd. Shareholders of record on Thursday, September 1st will be paid a $0.54 dividend. This is a boost from McKesson's previous quarterly dividend of $0.47. The ex-dividend date of this dividend is Wednesday, August 31st. This represents a $2.16 annualized dividend and a yield of 0.64%. McKesson's payout ratio is 22.83%.
该公司最近还披露了季度股息，将于10月3日星期一支付。9月1日星期四登记在册的股东将获得0.54美元的股息。这是对McKesson之前季度派息0.47美元的提振。本次股息除息日为8月31日(星期三)。这相当于年化股息2.16美元，收益率为0.64%。McKesson的派息率为22.83%。
Insider Buying and Selling at McKesson
McKesson的内幕买卖
In other news, EVP Lori A. Schechter sold 7,500 shares of McKesson stock in a transaction that occurred on Thursday, September 15th. The shares were sold at an average price of $343.94, for a total value of $2,579,550.00. Following the completion of the sale, the executive vice president now directly owns 11,678 shares in the company, valued at $4,016,531.32. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, EVP Lori A. Schechter sold 7,500 shares of the stock in a transaction on Thursday, September 15th. The stock was sold at an average price of $343.94, for a total transaction of $2,579,550.00. Following the sale, the executive vice president now directly owns 11,678 shares of the company's stock, valued at approximately $4,016,531.32. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Thomas L. Rodgers sold 1,300 shares of the business's stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $367.21, for a total value of $477,373.00. Following the completion of the transaction, the executive vice president now directly owns 2,544 shares of the company's stock, valued at approximately $934,182.24. The disclosure for this sale can be found here. Insiders own 0.21% of the company's stock.
在其他新闻方面，执行副总裁洛里·A·谢克特在9月15日星期四的一笔交易中出售了7,500股麦凯森股票。这些股票的平均价格为343.94美元，总价值为2579,550.00美元。出售完成后，执行副总裁总裁现在直接持有该公司11678股，价值4016531.32美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，该文件可以通过这个环节。在其他新闻方面，执行副总裁洛里·A·谢克特在9月15日星期四的一次交易中出售了7500股该公司股票。股票以343.94美元的平均价格出售，总成交金额为2579,550.00美元。出售后，执行副总裁总裁现在直接持有该公司11678股股票，价值约4016531.32美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的，该文件可通过美国证券交易委员会网站。此外，执行副总裁托马斯·L·罗杰斯在一笔日期为9月8日星期四的交易中出售了1300股该公司股票。这些股票的平均价格为367.21美元，总价值为477,373.00美元。交易完成后，执行副总裁总裁现在直接持有2544股公司股票，价值约934,182.24美元。关于这次销售的披露可以找到这里。内部人士持有该公司0.21%的股份。
About McKesson
关于麦凯森
(Get Rating)
(获取评级)
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products.
McKesson公司在美国和国际上提供医疗服务。它通过四个部门运作：美国制药、国际、医疗-外科解决方案和处方技术解决方案(RxTS)。美国制药部门分销品牌、仿制药、特效药、生物相似药和非处方药以及其他与医疗保健相关的产品。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on McKesson (MCK)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Declining Profits Challenge the CarMax Value Proposition
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- 免费获取StockNews.com关于McKesson(MCK)的研究报告
- 电动汽车电池制造商Freyr将在全球大举扩张
- MarketBeat：回顾一周9/26-9/30
- 这是买入美光科技的难忘时刻
- 利润下降对CarMax价值主张的挑战
- Keurig Dr Pepper与规模更大的竞争对手可口可乐(Coke&Pepsi)相比如何？
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
接受McKesson Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对McKesson和相关公司的最新新闻和分析师评级的每日简要摘要。